The FasterCures Track: October 2013 - The P4C Advance

  Subscribe »

FasterCures' October newsletter header

We are gearing up for the 5th Partnering for Cures, Nov. 3-5 in New York – a platform for big ideas, transformative programs, and tangible results brought forth by some of the most disruptive innovators. Each year, a kinetic energy permeates this meeting as participants are bound by a shared sense of urgency and a drive toward solutions.

We measure the impact of this conference by the progress each participant can make – whether it’s finding vital new partners or garnering the latest intel on innovative programs or leaving with new vantage points to approach a problem (see below for the full agenda). We’ve designed the program to do just that:

Partnering for Cures speakers

  • 16 dynamic panel discussions will tackle issues that are key to advancing medical progress. From big science to big data to big systems, the issues at hand are immense. With more than 80 panelists focused on collaborative solutions that are forward-thinking and pragmatic, we know that participants will leave with great optimism and practical strategies.
  • 30 innovators will be presenting their cross-sector programs – chosen after the most competitive application cycle to date. From novel financing models to adaptive clinical trial designs to data sharing initiatives, these programs provide all of us with a first-person account of the innovation that is underway. The transformative nature of these programs is sure to have ripple effects for years to come.
  • P4C Connect makes partnering easy. This system allows participants – from innovators to investors, scientists to philanthropists, federal officials to advocates – to find each other and advance their own R&D goals. Through this system, registrants can also request private pro bono consulting sessions with dozens of leading experts ready to give advice on topics including attracting capital, collaboration structuring, and regulatory and reimbursement strategy.
  • Time Equals Lives Talks will feature remarkable speakers with incredible stories to tell about what drives them to continue to pave the path toward solutions – sometimes against many odds. Each 10-minute story will bring to life the personal factors that come to play in the search for cures. Speakers include Nancy Brinker of the Susan G. Komen Foundation and Susan Love of the Dr. Susan Love Research Foundation, Meryl Comer of the Geoffrey Beene Foundation Alzheimer’s Initiative and WomenAgainstAlzheimer’s, Geoffrey Ling of the Defense Advanced Research Projects Agency and Shari Ling of the Centers for Medicare & Medicaid Services, and Kafui Dzirasa of the Department of Psychiatry and Behavioral Sciences, Center for Neuroengineering, Duke University Medical Center.
  • Numerous opportunities for productive collisions, starting with breakfast roundtables focused on therapeutic affinity areas or research tools, networking opportunities throughout, and a late night gathering that will entertain and inspire.

And to continue the conversations beyond the meeting rooms, be sure to follow #P4C2013 on Twitter. We look forward to engaging with you. If you haven’t yet, you may still register at

Margaret's signature

Margaret Anderson
Executive Director

FasterCures logo

FasterCures Updates

FasterCures expands team with senior fellow and director of strategic initiatives

Robert Cook-Deegan Kimberly McCleary
Robert Cook-Deegan, Senior Fellow K. Kimberly McCleary, Director of Strategic Initiatves

FasterCures has announced that Robert Cook-Deegan, renowned geneticist and ethicist, has joined the team as one of its senior fellows and will work on projects that will help FasterCures build consensus around innovative solutions to important public policy challenges in the life sciences industry and medical R&D ecosystem. Cook-Deegan is a research professor at the Sanford School of Public Policy and the Institute for Genome Sciences & Policy at Duke University. In addition, K. Kimberly McCleary has joined FasterCures as director of strategic initiatives. McCleary will be leading the charge on key programmatic areas including FDA and how it evaluates risk and benefit for patients, and medical innovation and how we determine value and reimbursement.



Transitioning to open systems in drug discovery
open source blog quoteIn a new blog post, FasterCures Senior Fellow John Wilbanks says that bringing the ideas of “open source” into the pharmaceutical process is far from simple. It requires a careful understanding both of the realities of open source as a software development process as well as the realities of therapy research, development, and regulatory approval.


Give me your innovators yearning to breathe free
immigration blog infographicInnovation thrives, historically and in modern times, in places where cultures overlap, argues FasterCures Senior Fellow Bernard Munos in a blog post. It is as if innovation somehow comes more naturally to people who internalize various cultures, and both research and casual observation actually support that idea.

Partnering for Cures Agenda

  View full agenda »

6:00 PM - 8:00 PM Welcome Reception
7:00 AM - 7:00 PM Registration
7:00 AM - 8:00 AM Therapeutic Affinity & Research Building Blocks Breakfast Roundtables
8:00 AM - 9:00 AM Plenary: Big Science in the 21st Century
9:15 AM - 12:00 PM Partnering and Expert Consultations
9:15 AM - 10:10 AM Panel: The Other Translation Gap: Turning Outputs into Outcomes
  Panel: The Art and Science of Multi-Stakeholder Collaboration
  Panel: Philanthropy: Investing for Impact In the Search for Cures
10:15 AM - 10:40 AM Presentation: I-SPY 2 Collaboration
  Presentation: Harvard Medical School Center for Biomedical Informatics: People Powered Medicine
  Presentation: CQDM
10:45 AM - 11:10 AM Presentation: Health eHeart Study
  Presentation: Michael J. Fox Foundation: Parkinson's Data Challenge
  Presentation: Aeras: Business Case for Investment in Tuberculosis R & D
11:15 AM - 11:40 AM Presentation: A Faster Way Forward: Allegro's Innovative Approach to The Science & Business of Drug Development
  Presentation: Curious, Inc
  Presentation: Xalud Therapeutics, Inc.
12:00 PM - 1:30 PM Plenary: Investing in Bioscience: Linking Financial, Human, and Social Returns
1:45 PM - 6:00 PM Partnering/Expert Consultations
1:45 PM - 2:10 PM Presentation: Empowering Pediatric Research: ViS & BIO Collaboration
  Presentation: Friends of Cancer Research: Lung Cancer Master Protocol Trial
  Presentation: National Cancer Institute/Avon Breast Cancer Crusade/The Center for Advancing Innovation: Breast Cancer Startup Challenge
2:15 PM - 2:40 PM Presentation: Bessor/Brightwaters Pharma: Building Value Uniquely Translating University Assets
  Presentation: Foundation for the NIH: Biomarkers Consortium Sarcopenia Initiative
  Presentation: Immunophotonics: Changing the World, Providing Nontoxic, Practical, Cost-Effective Treatments to Cancer Patients Globally
2:45 PM - 3:10 PM Presentation: Kineta, Inc
  Presentation: Immune Tolerance Network: TrialShare Clinical Trials Research Portal
  Presentation: BIO Ventures for Global Health: A Bridge between Private Industry and Global Health Endeavors
3:15 PM - 3:40 PM Presentation: Pfizer's Centers for Therapeutic Innovation/Alliance for Lupus Research
  Presentation: Project Data Sphere Initiative
  Presentation: COPD Foundation: COPD Innovation Search
3:45 PM - 4:40 PM Panel: FDA: Recalibrating the Benefit-Risk Equation
  Panel: Learning To Love Failure
  Panel: Reducing Drag: New Approaches to IP Negotiation and Technology Licensing
4:45 PM - 6:00 PM Networking Reception
9:00 PM - 10:00 PM Partnering for Cures Late Night
7:00 AM - 1:00 PM Registration
7:00 AM - 8:00 AM Therapeutic Affinity & Research Building Blocks Breakfast Roundtables
8:00 AM - 9:00 AM Plenary: Five People Changing the Face of Bioscience
9:15 AM - 12:40 PM Partnering/Expert Consultations
9:15 AM - 10:10 AM Panel: The New Value Proposition for Academic Science
  Panel: Rare Diseases: Hot, but for How Long?
  Panel: Mental Health: Research and Development at a Crossroads
10:15 AM - 10:40 AM Presentation: Prostate Cancer Foundation
  Presentation: Parkinson's UK: Tracking Parkinson's (PRoBaND)
  Presentation: Melanoma Research Alliance: Academic-Industry Partnership
10:45 AM - 11:10 AM Presentation: Alzheimer's Drug Discovery Foundation ACCESS: A novel resource to optimize the use of CROs by academia and early-stage companies
  Presentation: Neurological Clinical Research Institute/Prize4Life: Pooled Resource Open-Access ALS Clinical Trials Platform (PRO-ACT)
  Presentation: Chemistry of Life Processes Institute: Accelerate Chicago!
11:15 AM - 11:40 AM Presentation: Leukemia & Lymphoma Society: Targets, Leads & Candidates Program
  Presentation: Lieber Institute for Brain Development
  Presentation: Carnegie Mellon University/Highmark: Disruptive Health Technology Institute
11:45 AM - 12:40 PM Panel: Reimbursement: Can Value Drive Innovation?
  Panel: Beyond Venture Capital
  Panel: The People Behind the Science: Will Work for Food
1:00 PM - 2:30 PM Plenary: Big Data Needs Big Ideas
2:45 PM - 4:40 PM Partnering/Expert Consultations
2:45 PM - 3:45 PM Time Equals Lives Talks
Until next issue

If you have questions or would like more information about any of the items above, please contact

Stay connected with FasterCures
facebook twitter linkedin tumblr youtube